Microscale functional cytomics for studying hematologic cancers

Por Young, Edmond W. K., Pak, Chorom, Kahl, Brad S., Yang, David T., Callander, Natalie S., Miyamoto, Shigeki, Beebe, David J.
Publicado em 2012

Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myeloma

Por Stewart, A. Keith, Jacobus, Susanna, Fonseca, Rafael, Weiss, Matthias, Callander, Natalie S., Chanan-Khan, Asher A., Rajkumar, S. Vincent
Publicado no Blood (2015)

Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma

Por Chang, Julie E., Juckett, Mark B., Callander, Natalie S., Kahl, Brad S., Gangnon, Ronald E., Mitchell, Teri L., Longo, Walter L.
Publicado em 2008

Negative Regulation of the Tumor Suppressor p53 Gene by MicroRNAs

Por Kumar, Munish, Lu, Zhongxin, Takwi, Apana Agha L., Chen, Weiqun, Callander, Natalie S., Ramos, Kenneth S., Young, Ken H., Li, Yong
Publicado em 2010

Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells

Por Kim, Jaehyup, Denu, Ryan A, Dollar, Bridget A, Escalante, Leah E, Kuether, Justin P, Callander, Natalie S, Asimakopoulos, Fotis, Hematti, Peiman
Publicado em 2012

Macrophages in multiple myeloma: emerging concepts and therapeutic implications

Por Asimakopoulos, Fotis, Kim, Jaehyup, Denu, Ryan A., Hope, Chelsea, Jensen, Jeffrey L., Ollar, Samuel J., Hebron, Ellen, Flanagan, Claire, Callander, Natalie, Hematti, Peiman
Publicado em 2013

Acetyl-l-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxoru...

Por Callander, Natalie, Markovina, Stephanie, Eickhoff, Jens, Hutson, Paul, Campbell, Toby, Hematti, Peiman, Go, Ronald, Hegeman, Robert, Longo, Walter, Williams, Eliot, Asimakopoulos, Fotis, Miyamoto, Shigeki
Publicado em 2014

Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma

Por Kumar, Shaji K., LaPlant, Betsy, Chng, Wee Joo, Zonder, Jeffrey, Callander, Natalie, Fonseca, Rafael, Fruth, Briant, Roy, Vivek, Erlichman, Charles, Stewart, A. Keith
Publicado no Blood (2015)

MicroC(3): an ex vivo microfluidic cis-coculture assay to test chemosensitivity and resistance of patient multiple myeloma cells

Por Pak, Chorom, Callander, Natalie S., Young, Edmond W. K., Titz, Benjamin, Kim, KyungMann, Saha, Sandeep, Chng, Kenny, Asimakopoulos, Fotis, Beebe, David J., Miyamoto, Shigeki
Publicado no Integr Biol (Camb) (2015)

Bortezomib-Resistant NF-κB Activity in Multiple Myeloma Cells

Por Markovina, Stephanie, Callander, Natalie S, O’Connor, Shelby L, Kim, Jihoon, Werndli, Jae E, Raschko, Martha, Leith, Catherine P, Kahl, Brad S, Kim, KyungMann, Miyamoto, Shigeki
Publicado em 2008

MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages

Por Hebron, Ellen, Hope, Chelsea, Kim, Jaehyup, Jensen, Jeffrey L., Flanagan, Claire, Bhatia, Neehar, Maroulakou, Ioanna, Mitsiades, Constantine, Miyamoto, Shigeki, Callander, Natalie, Hematti, Peiman, Asimakopoulos, Fotis
Publicado em 2012

Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells

Por Markovina, Stephanie, Callander, Natalie S, O'Connor, Shelby L, Xu, Guangwu, Shi, Yufang, Leith, Catherine P, Kim, KyungMann, Trivedi, Parul, Kim, Jaehyup, Hematti, Peiman, Miyamoto, Shigeki
Publicado em 2010

In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2

Por Maes, Ken, Nemeth, Elizabeta, Roodman, G. David, Huston, Alissa, Esteve, Flavia, Freytes, Cesar, Callander, Natalie, Katodritou, Eirini, Tussing-Humphreys, Lisa, Rivera, Seth, Vanderkerken, Karin, Lichtenstein, Alan, Ganz, Tomas
Publicado em 2010

Immunoregulatory roles of versican proteolysis in the myeloma microenvironment

Por Hope, Chelsea, Foulcer, Simon, Jagodinsky, Justin, Chen, Sarah X., Jensen, Jeffrey L., Patel, Sanjay, Leith, Catherine, Maroulakou, Ioanna, Callander, Natalie, Miyamoto, Shigeki, Hematti, Peiman, Apte, Suneel S., Asimakopoulos, Fotis
Publicado no Blood (2016)

Tumoricidal Effects of Macrophage-activating Immunotherapy in a Murine Model of Relapsed/ Refractory Multiple Myeloma

Por Jensen, Jeffrey L., Rakhmilevich, Alexander, Heninger, Erika, Broman, Aimee Teo, Hope, Chelsea, Phan, Funita, Miyamoto, Shigeki, Maroulakou, Ioanna, Callander, Natalie, Hematti, Peiman, Chesi, Marta, Bergsagel, P. Leif, Sondel, Paul, Asimakopoulos, Fotis
Publicado no Cancer Immunol Res (2015)

Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone

Por Kumar, Shaji K., Uno, Hajime, Jacobus, Susanna J., Wier, Scott A. Van, Ahmann, Greg J., Henderson, Kimberly J., Callander, Natalie S., Haug, Jessica L., Siegel, David S., Greipp, Philip R., Fonseca, Rafael, Rajkumar, S. Vincent
Publicado em 2011

TPL2 kinase regulates the inflammatory milieu of the myeloma niche

Por Hope, Chelsea, Ollar, Samuel J., Heninger, Erika, Hebron, Ellen, Jensen, Jeffrey L., Kim, Jaehyup, Maroulakou, Ioanna, Miyamoto, Shigeki, Leith, Catherine, Yang, David T., Callander, Natalie, Hematti, Peiman, Chesi, Marta, Bergsagel, P. Leif, Asimakopoulos, Fotis
Publicado em 2014

Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra(®), TLK199), a novel glutathione analog prodrug in patients with myelodys...

Por Raza, Azra, Galili, Naomi, Callander, Natalie, Ochoa, Leonel, Piro, Lawrence, Emanuel, Peter, Williams, Stephanie, Burris, Howard, Faderl, Stefan, Estrov, Zeev, Curtin, Peter, Larson, Richard A, Keck, James G, Jones, Marsha, Meng, Lisa, Brown, Gail L
Publicado em 2009

Single-molecule analysis reveals widespread structural variation in multiple myeloma

Por Gupta, Aditya, Place, Michael, Goldstein, Steven, Sarkar, Deepayan, Zhou, Shiguo, Potamousis, Konstantinos, Kim, Jaehyup, Flanagan, Claire, Li, Yang, Newton, Michael A., Callander, Natalie S., Hematti, Peiman, Bresnick, Emery H., Ma, Jian, Asimakopoulos, Fotis, Schwartz, David C.
Publicado no Proc Natl Acad Sci U S A (2015)

Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis

Por Kumar, Shaji, Zhang, Mei-Jie, Li, Peigang, Dispenzieri, Angela, Milone, Gustavo A., Lonial, Sagar, Krishnan, Amrita, Maiolino, Angelo, Wirk, Baldeep, Weiss, Brendan, Freytes, César O., Vogl, Dan T., Vesole, David H., Lazarus, Hillard M., Meehan, Kenneth R., Hamadani, Mehdi, Lill, Michael, Callander, Natalie S., Majhail, Navneet S., Wiernik, Peter H., Nath, Rajneesh, Kamble, Rammurti T., Vij, Ravi, Kyle, Robert A., Gale, Robert Peter, Hari, Parameswaran N.
Publicado em 2011